Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M
Med Oncol. 2025; 42(4):108.
PMID: 40087196
DOI: 10.1007/s12032-025-02675-8.
Ogawa H, Yoshida K, Hasegawa S, Wada H, Yasui M, Tahara H
Front Oncol. 2025; 15:1485886.
PMID: 40078183
PMC: 11896854.
DOI: 10.3389/fonc.2025.1485886.
Baster Z, Russell L, Rajfur Z
Int J Mol Sci. 2025; 26(5).
PMID: 40076426
PMC: 11899650.
DOI: 10.3390/ijms26051798.
Qi J, Yu K, Liu B, Wang Y, Wang W, An R
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40074843
DOI: 10.1007/s00210-025-03998-z.
Ren S, Zhang Y, Wang X, Su J, Wang X, Yuan Z
Front Immunol. 2025; 16:1526967.
PMID: 40070843
PMC: 11893557.
DOI: 10.3389/fimmu.2025.1526967.
Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments.
Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H
NPJ Precis Oncol. 2025; 9(1):68.
PMID: 40069556
PMC: 11897387.
DOI: 10.1038/s41698-025-00857-1.
Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming.
Wang S, Chen Y, Huang S, Fu Y, Lin S, Jiang S
Oncogenesis. 2025; 14(1):6.
PMID: 40069143
PMC: 11897235.
DOI: 10.1038/s41389-025-00549-2.
Pharmacological aspects of FDA-approved novel drug therapies against cancer in 2023: a comprehensive review.
Sangwan K, Goyal P, Sharma V
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40067439
DOI: 10.1007/s00210-025-03961-y.
Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness.
Camargo S, Moskowitz O, Giladi A, Levinson M, Balaban R, Gola S
Nat Cancer. 2025; .
PMID: 40055573
DOI: 10.1038/s43018-025-00924-3.
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y
Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311
PMC: 11889221.
DOI: 10.1038/s41392-025-02124-y.
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.
Suri C, Pande B, Suhasini Sahithi L, Swarnkar S, Khelkar T, Verma H
Cancer Drug Resist. 2025; 8:7.
PMID: 40051496
PMC: 11883236.
DOI: 10.20517/cdr.2024.164.
Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation.
Chen C, Fu Q, Wang L, Tanaka S, Imajo M
BMC Cancer. 2025; 25(1):405.
PMID: 40050746
PMC: 11884030.
DOI: 10.1186/s12885-025-13834-5.
Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D.
Seo R, de Guzman A, Park S, Lee J, Kang S
Cell Death Differ. 2025; .
PMID: 40050422
DOI: 10.1038/s41418-025-01466-y.
Myeloid cells: key players in tumor microenvironments.
Hua Q, Li Z, Weng Y, Wu Y, Zheng L
Front Med. 2025; .
PMID: 40048137
DOI: 10.1007/s11684-025-1124-8.
Pan-cancer investigation regarding the prognostic predictive and immunological regulation functions of PGK1 and experimental validation in esophageal squamous cell carcinoma.
Chen J, Wu X, Luo H, Wang D, Dong M, Wang Y
Funct Integr Genomics. 2025; 25(1):54.
PMID: 40047969
DOI: 10.1007/s10142-025-01555-8.
Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.
Amaral A, Finardi G, Marchi P, de Oliveira N, Principe L, Teixeira N
Front Vet Sci. 2025; 11:1490290.
PMID: 40046187
PMC: 11881598.
DOI: 10.3389/fvets.2024.1490290.
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration.
Wang H, Liu X, Huang H, Tang M, Li J, Huang T
Front Immunol. 2025; 16:1510503.
PMID: 40046044
PMC: 11880792.
DOI: 10.3389/fimmu.2025.1510503.
The emerging role of glycolysis and immune evasion in ovarian cancer.
Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y
Cancer Cell Int. 2025; 25(1):78.
PMID: 40045411
PMC: 11881340.
DOI: 10.1186/s12935-025-03698-x.
Prognostic and Therapeutic Significance of Cancer-Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single-Cell RNA Sequencing Data.
Que Y, Ding T, Wang H, Xu S, He P, Shen Q
J Cell Mol Med. 2025; 29(5):e70424.
PMID: 40045162
PMC: 11882394.
DOI: 10.1111/jcmm.70424.
Elevated CD10 neutrophils correlate with non-response and poor prognosis of CD19 CAR T-cell therapy for B-cell acute lymphoblastic leukemia.
Zhu J, Zhou J, Liang X, An F, Ding Y, Jiao X
BMC Med. 2025; 23(1):138.
PMID: 40038688
PMC: 11881286.
DOI: 10.1186/s12916-025-03968-5.